CN204203238U - 一种检测抗环瓜氨酸肽抗体的试剂盒 - Google Patents
一种检测抗环瓜氨酸肽抗体的试剂盒 Download PDFInfo
- Publication number
- CN204203238U CN204203238U CN201420738005.XU CN201420738005U CN204203238U CN 204203238 U CN204203238 U CN 204203238U CN 201420738005 U CN201420738005 U CN 201420738005U CN 204203238 U CN204203238 U CN 204203238U
- Authority
- CN
- China
- Prior art keywords
- pad
- liner
- detection layers
- sample
- nitrocellulose filter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 125000004122 cyclic group Chemical group 0.000 title claims abstract description 19
- 238000001514 detection method Methods 0.000 claims abstract description 65
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000010931 gold Substances 0.000 claims abstract description 38
- 229910052737 gold Inorganic materials 0.000 claims abstract description 38
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 27
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 27
- 239000004033 plastic Substances 0.000 claims abstract description 11
- 238000010521 absorption reaction Methods 0.000 claims abstract description 10
- 241001494479 Pecora Species 0.000 claims abstract description 5
- 239000002245 particle Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000084 colloidal system Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000004816 latex Substances 0.000 claims description 2
- 229920000126 latex Polymers 0.000 claims description 2
- 239000006249 magnetic particle Substances 0.000 claims description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 8
- 238000003745 diagnosis Methods 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 description 14
- 230000001276 controlling effect Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 7
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 238000003908 quality control method Methods 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 239000002390 adhesive tape Substances 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 108010061103 cyclic citrullinated peptide Proteins 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SJUCACGNNJFHLB-UHFFFAOYSA-N O=C1N[ClH](=O)NC2=C1NC(=O)N2 Chemical compound O=C1N[ClH](=O)NC2=C1NC(=O)N2 SJUCACGNNJFHLB-UHFFFAOYSA-N 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 230000003456 anti-perinuclear Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001258 synovial membrane Anatomy 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
病例 | 性别 | 年龄 | 诊断 | 盲检结果 |
1 | 女 | 40 | RA | + |
2 | 男 | 41 | - | - |
3 | 男 | 54 | RA | + |
4 | 男 | 37 | RA | + |
5 | 女 | 22 | RA | + |
6 | 男 | 31 | - | - |
7 | 男 | 33 | RA | + |
8 | 男 | 39 | RA | + |
9 | 女 | 10 | - | - |
10 | 女 | 47 | RA | + |
11 | 女 | 49 | RA | + |
12 | 男 | 28 | - | - |
13 | 女 | 42 | RA | + |
14 | 男 | 26 | - | - |
15 | 女 | 28 | - | - |
16 | 男 | 33 | RA | + |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201420738005.XU CN204203238U (zh) | 2014-11-26 | 2014-11-26 | 一种检测抗环瓜氨酸肽抗体的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201420738005.XU CN204203238U (zh) | 2014-11-26 | 2014-11-26 | 一种检测抗环瓜氨酸肽抗体的试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN204203238U true CN204203238U (zh) | 2015-03-11 |
Family
ID=52661183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201420738005.XU Expired - Fee Related CN204203238U (zh) | 2014-11-26 | 2014-11-26 | 一种检测抗环瓜氨酸肽抗体的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN204203238U (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106644985A (zh) * | 2016-12-29 | 2017-05-10 | 广州市雷德生物科技有限公司 | 标志物及其应用、试剂盒、该标志物的检测方法 |
CN111308096A (zh) * | 2020-03-05 | 2020-06-19 | 深圳市睿盟创新科技有限公司 | 用于类风湿性关节炎检测的胶体金试纸条 |
CN115792223A (zh) * | 2023-01-13 | 2023-03-14 | 山东康华生物医疗科技股份有限公司 | 一种抗环瓜氨酸肽抗体检测试剂盒 |
-
2014
- 2014-11-26 CN CN201420738005.XU patent/CN204203238U/zh not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106644985A (zh) * | 2016-12-29 | 2017-05-10 | 广州市雷德生物科技有限公司 | 标志物及其应用、试剂盒、该标志物的检测方法 |
CN106644985B (zh) * | 2016-12-29 | 2021-02-05 | 广州市雷德生物科技有限公司 | 标志物及其应用、试剂盒、该标志物的检测方法 |
CN111308096A (zh) * | 2020-03-05 | 2020-06-19 | 深圳市睿盟创新科技有限公司 | 用于类风湿性关节炎检测的胶体金试纸条 |
CN115792223A (zh) * | 2023-01-13 | 2023-03-14 | 山东康华生物医疗科技股份有限公司 | 一种抗环瓜氨酸肽抗体检测试剂盒 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105548534B (zh) | 心肌标志物的联合检测装置及其制备方法 | |
CN202794189U (zh) | C反应蛋白快速全程定量免疫层析检测试剂盒 | |
CN104316685B (zh) | 一种二乙酰精胺的检测试剂盒及制备方法和应用 | |
US20210011037A1 (en) | Lateral flow immunoassays for the detection of antibodies against biological drugs | |
CN102854324B (zh) | 快速无损伤性检测肝肿瘤标志物的方法以及采用的试纸条 | |
CN204203238U (zh) | 一种检测抗环瓜氨酸肽抗体的试剂盒 | |
CN107688090A (zh) | 一种NTx检测试纸、试剂盒及其制备方法 | |
CN110646624A (zh) | 一种基质素2的elisa试剂诊断盒及其使用方法 | |
CN101004421B (zh) | 一种半定量检测oxLDL的试纸 | |
CN106546750A (zh) | 一种微量白蛋白快速定量检测试纸条的制备及检测方法 | |
CN110196330A (zh) | 一种检测骆驼乳中掺伪牛乳的免疫胶体金试纸条及其应用 | |
CN105785028A (zh) | 一种检测人心力衰竭新型标志物st2的快速诊断试剂盒 | |
CN202735352U (zh) | 一种检测人心力衰竭新型标志物st2的快速诊断试剂盒 | |
CN110221066A (zh) | 一种旋毛虫病荧光免疫层析检测试纸条及其制备方法与应用 | |
CN106198983A (zh) | 用于卵巢癌检测的试剂盒 | |
CN101320042A (zh) | 抗角蛋白抗体的检测方法及试剂盒 | |
CN204719056U (zh) | 一种快速联合检测he4和ca125的试剂盒 | |
CN107271692A (zh) | 一种标记特异性高亲和力重组抗体的荧光微球及其应用 | |
CN202837303U (zh) | Ngal荧光免疫层析定量检测试纸条 | |
JP3848599B2 (ja) | 簡易メンブレンアッセイ法及びキット | |
CN104764884A (zh) | 一种抗alpha-烯醇化酶抗体层析试纸条及其用途 | |
CN107490698A (zh) | 一种检测试剂盒及其应用 | |
CN209102728U (zh) | 一种微柱凝集抗人球蛋白检测卡 | |
CN203101402U (zh) | 甲胎蛋白快速定量免疫层析检测试剂盒 | |
CN203688564U (zh) | 一种人绒毛膜促性腺激素和细菌性阴道炎联检试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of utility model: A kit for detecting anti cyclic citrullinated peptide antibody Effective date of registration: 20210412 Granted publication date: 20150311 Pledgee: Hangzhou United Rural Commercial Bank Co.,Ltd. Xixing sub branch Pledgor: HANGZHOU WATSON BIOTECH Inc. Registration number: Y2021330000294 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220211 Granted publication date: 20150311 Pledgee: Hangzhou United Rural Commercial Bank Co.,Ltd. Xixing sub branch Pledgor: HANGZHOU WATSON BIOTECH Inc. Registration number: Y2021330000294 |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Liu Bilian Document name: payment instructions |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Liu Bilian Document name: Notice of Termination of Patent Rights |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150311 |